Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study

医学 视神经脊髓炎 内科学 比例危险模型 队列 回顾性队列研究 多发性硬化 免疫学
作者
Pakeeran Siriratnam,Paul Gerard Sanfilippo,Anneke van der Walt,Sifat Sharmin,Yi Chao Foong,Wei Zhen Yeh,Chao Zhu,Samia Joseph Khoury,Tünde Csépány,Barbara M. P. Willekens,Masoud Etemadifar,Serkan Özakbaş,Petra Nytrová,Ayşe Altıntaş,Abdullah Rashid Al-Asmi,Bassem Yamout,Guy Laureys,Francesco Patti,Magdolna Simó,Andrea Surcinelli
出处
期刊:Journal of Neurology, Neurosurgery, and Psychiatry [BMJ]
卷期号:96 (4): 361-369 被引量:20
标识
DOI:10.1136/jnnp-2024-334090
摘要

BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) can be categorised into aquaporin-4 antibody (AQP4-IgG) NMOSD or seronegative NMOSD. While our knowledge of AQP4-IgG NMOSD has evolved significantly in the past decade, seronegative NMOSD remains less understood. This study aimed to evaluate the predictors of relapses and treatment responses in AQP4-IgG NMOSD and seronegative NMOSD. METHODS: This was a multicentre, international, retrospective cohort study using the MSBase registry. Recurrent relapse risk was assessed using an Andersen-Gill model and risk of first relapse was evaluated using a Cox proportional hazards model. Covariates that putatively influence relapse risk included demographic factors, clinical characteristics and immunosuppressive therapies; the latter was assessed as a time-varying covariate. RESULTS: A total of 398 patients (246 AQP4-IgG NMOSD and 152 seronegative NMOSD) were included. The AQP4-IgG NMOSD and seronegative NMOSD patients did not significantly differ by age at disease onset, ethnicity or annualised relapse rate. Both low-efficacy and high-efficacy immunosuppressive therapies were associated with significant reductions in recurrent relapse risk, with notably greater protection conferred by high-efficacy therapies in both AQP4-IgG NMOSD (HR 0.27, 95% CI 0.15 to 0.49, p<0.001) and seronegative NMOSD (HR 0.21, 95% CI 0.08 to 0.51, p<0.001). Longer disease duration (HR 0.97, 95% CI 0.95 to 0.99, p<0.001) and male sex (HR 0.52, 95% CI 0.34 to 0.84, p=0.007) were additional protective variables in reducing the recurrent relapse risk for the AQP4-IgG NMOSD group. CONCLUSION: Although further studies are needed to improve our understanding of seronegative NMOSD, our findings underscore the importance of aggressive treatment with high-efficacy immunotherapies in both NMOSD subtypes, regardless of serostatus.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SunAuole发布了新的文献求助10
1秒前
Seorina发布了新的文献求助30
1秒前
2秒前
3秒前
英吉利25发布了新的文献求助10
3秒前
3秒前
3秒前
李春阳完成签到,获得积分10
4秒前
4秒前
5秒前
wen发布了新的文献求助50
5秒前
6秒前
vbmc发布了新的文献求助30
9秒前
11秒前
12秒前
顾矜的应助被俏皮诺言采纳,获得10
12秒前
12秒前
cdercder的应助被tlc_191026采纳,获得30
16秒前
XY完成签到,获得积分20
16秒前
darkegg完成签到,获得积分10
17秒前
17秒前
17秒前
赵医生完成签到,获得积分10
17秒前
水弘的应助被陶醉的筮采纳,获得10
18秒前
daomaihu发布了新的文献求助100
18秒前
My_magnum_opus给gaoxueli的求助进行了留言
18秒前
xiaolizi发布了新的文献求助30
19秒前
852的应助被1192237414采纳,获得10
20秒前
赵医生发布了新的文献求助10
20秒前
Krositon发布了新的文献求助10
20秒前
21秒前
情怀的应助被panada采纳,获得10
21秒前
WEN完成签到,获得积分10
21秒前
Lucas的应助被Jonathan采纳,获得10
21秒前
小冯完成签到,获得积分10
22秒前
22秒前
matou发布了新的文献求助20
24秒前
Tinker完成签到,获得积分10
24秒前
25秒前
李仟亿发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183508
求助须知:如何正确求助?哪些是违规求助? 9572862
关于积分的说明 21827639
捐赠科研通 7780681
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480405